The clinical trials consulting and documentation company, which is headquartered in Dedham with a second location in the Netherlands, works with healthcare and life science partners to deliver important new therapies to patients.

“We are honored to receive this recognition from the Boston Business Journal (BBJ) for the third time in three years,” said Synterex President Jeanette Towles. “This would not be possible without our trusted clients, the patients who participate in clinical trials, or our incredible team. To our writers, software engineers and administrative team, thank you for making this possible.”

The BBJ’s Fast 50 list is selected and ranked by the publication’s research department. To be considered for the list, companies must be headquartered in Massachusetts and must have reported revenue of at least $500,000 in 2020 and $1 million in 2023. Synterex’s growth was fueled in 2023 by the development of several new services and software, such as its AI-powered document production and management software, AgileWriter™.


"We are so excited to celebrate this year's Fast 50, bringing together the leaders, founders and professionals working at the region's fastest-growing private companies," said Carolyn M. Jones, market president and publisher of the Boston Business Journal.

A Fast 50 special publication is scheduled to run in the May 17 weekly edition of the Business Journal and online that week as well. A celebration to honor this year's Fast 50 is scheduled to be held on Thursday, May 16th at the Aloft Boston Seaport Hotel where the rankings will be released.

For more information about Synterex, visit synterex.com, email [email protected] or call (888) 760-9906.

###

About Synterex, Inc.
Synterex is a woman-owned (WBENC), disability-owned (DOBE) clinical and regulatory consulting firm specializing in agile methodology, automation, and artificial intelligence (AI)-driven technologies. We have extensive experience doing the work hands-on as well as building and leading teams. We help clients deliver important new therapies to patients in an expedient manner.

About the Boston Business Journal
The Boston Business Journal is the region's premier business media organization, one of 44 markets owned by American City Business Journals. For marketing and sponsorship opportunities, contact the Business Journal today: https://advertise.bizjournals.com/brands/boston/?ana=om_bost_wb_dg_ftr.